Antibe Therapeutics Inc.’ Founder Leads Study Identifying A Novel Mechanism For Treating Inflammatory Bowel Disease

TORONTO--(BUSINESS WIRE)--Antibe Therapeutics Inc.’s Founder and Chief Scientific Officer, Dr. John Wallace, is the senior author of an article published this week in the prestigious scientific journal Proceedings of the National Academy of Science USA describing research that may lead to a significant improvement in the treatment of Crohn’s Disease and Ulcerative Colitis, collectively known as “inflammatory bowel disease” (IBD).

Help employers find you! Check out all the jobs and post your resume.